LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in LENZ Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +4 vs. Q3 2022
- Shares held
- 28.8M
- −815.9K (−2.8%) vs. Q3 2022
- Total value
- $95.6M
- +$1.72M (+1.8%) vs. Q3 2022
- New holders
- 13
- 21 more added
- Sold out
- 9
- 15 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 8,459,314 | $28.1M | 6.05% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,712,096 | $19.0M | 0.58% | +4,129,961+261.0% | Added |
| Avidity Partners Management LP | 1,575,000 | $5.23M | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,226,916 | $4.07M | 0.00% | +26,634+2.2% | Added |
| Citadel Advisors LLC | 1,190,415 | $3.95M | 0.00% | −83,632−6.6% | Reduced |
| FMR LLC | 1,116,123 | $3.71M | 0.00% | −3,756,635−77.1% | Reduced |
| Tang Capital Management LLC | 1,100,000 | $3.65M | 0.53% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,058,501 | $3.51M | 0.01% | +5180.0% | Added |
| Prosight Management, LP | 916,558 | $3.04M | 1.70% | +560,113+157.1% | Added |
| Artal Group S.A. | 700,000 | $2.32M | 0.13% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 612,505 | $2.03M | 1.55% | +47,559+8.4% | Added |
| Laurion Capital Management LP | 573,600 | $1.90M | 0.05% | 00.0% | Unchanged |
| BlackRock Inc. | 520,591 | $1.73M | 0.00% | +37,624+7.8% | Added |
| Board of Trustees of The Leland Stanford Junior University | 459,287 | $1.52M | 0.15% | −243,784−34.7% | Reduced |
| OUP Management Co., LLC | 406,308 | $1.35M | 2.20% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 329,872 | $1.09M | 0.00% | −192,097−36.8% | Reduced |
| Two Sigma Advisers, LP | 255,200 | $847.3K | 0.00% | −11,200−4.2% | Reduced |
| Oasis Management Co Ltd. | 255,102 | $846.9K | 0.18% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 242,536 | $805.0K | 0.00% | +22,666+10.3% | Added |
| Gsa Capital Partners LLP | 214,492 | $712.0K | 0.09% | +23,789+12.5% | Added |
| Two Sigma Investments, LP | 208,367 | $691.8K | 0.00% | −51,961−20.0% | Reduced |
| Cormorant Asset Management, LP | 199,547 | $662.0K | 0.04% | 00.0% | Unchanged |
| Millennium Management LLC | 133,344 | $443.0K | 0.00% | −217,325−62.0% | Reduced |
| Bridgeway Capital Management, LLC | 130,500 | $433.3K | 0.01% | +17,000+15.0% | Added |
| Man Group plc | 111,798 | $371.2K | 0.00% | +72,573+185.0% | Added |
| Anson Funds Management LP | 112,176 | $358.8K | 0.12% | +112,176 | New |
| State Street Corp | 89,151 | $296.0K | 0.00% | +41,700+87.9% | Added |
| Bank of Montreal | 82,400 | $273.6K | 0.00% | +82,400 | New |
| Northern Trust Corp | 78,734 | $261.4K | 0.00% | +15,640+24.8% | Added |
| Citigroup Inc | 71,155 | $236.2K | 0.00% | +70,358+8,827.9% | Added |
| Cornercap Investment Counsel Inc | 66,427 | $220.5K | 0.04% | 00.0% | Unchanged |
| Bank of America Corp | 52,539 | $174.4K | 0.00% | +14,793+39.2% | Added |
| 683 Capital Management, LLC | 52,306 | $173.7K | 0.02% | +52,306 | New |
| Dimensional Fund Advisors LP | 49,319 | $164.0K | 0.00% | +38,667+363.0% | Added |
| Morgan Stanley | 35,298 | $117.2K | 0.00% | +3,975+12.7% | Added |
| Prelude Capital Management, LLC | 34,199 | $113.5K | 0.01% | +1,300+4.0% | Added |
| Susquehanna International Group, LLP | 33,635 | $111.7K | 0.00% | +33,635 | New |
| D. E. Shaw & Co., Inc. | 30,284 | $100.5K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 28,602 | $95.0K | 0.00% | −223,132−88.6% | Reduced |
| Boothbay Fund Management, LLC | 28,463 | $94.5K | 0.00% | +28,463 | New |
| K2 Principal Fund, L.P. | 28,424 | $94.4K | 0.03% | +28,424 | New |
| Qube Research & Technologies Ltd | 27,103 | $90.0K | 0.00% | +7,110+35.6% | Added |
| Acadian Asset Management LLC | 25,799 | $85.0K | 0.00% | +25,799 | New |
| Belvedere Trading LLC | 22,121 | $73.4K | 0.04% | +22,121 | New |
| Annandale Capital, LLC | 17,930 | $60.0K | 0.02% | +17,930 | New |
| Charles Schwab Investment Management Inc | 17,740 | $58.9K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 15,866 | $52.7K | 0.00% | −15,434−49.3% | Reduced |
| Occudo Quantitative Strategies LP | 14,833 | $49.2K | 0.01% | −8,645−36.8% | Reduced |
| Cannell Capital LLC | 14,308 | $47.5K | 0.01% | 00.0% | Unchanged |
| Lodestar Private Asset Management LLC | 14,199 | $47.1K | 0.01% | +14,199 | New |
| Cubist Systematic Strategies, LLC | 13,968 | $46.4K | 0.00% | −1,605−10.3% | Reduced |
| Erste Asset Management GmbH | 11,900 | $38.3K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,911 | $13.0K | 0.00% | −2,359−37.6% | Reduced |
| Wells Fargo & Company | 3,353 | $11.1K | 0.00% | −195−5.5% | Reduced |
| Simplex Trading, LLC | 3,346 | $11.0K | 0.00% | −34,791−91.2% | Reduced |
| Advisor Group Holdings, Inc. | 3,090 | $10.1K | 0.00% | +20+0.7% | Added |
| Tower Research Capital LLC (TRC) | 2,116 | $7.00K | 0.00% | −4,365−67.4% | Reduced |
| Lazard Asset Management LLC | 2,206 | $7.00K | 0.00% | +2,206 | New |
| Quantbot Technologies LP | 1,600 | $5.31K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,526 | $5.07K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 591 | $1.96K | 0.00% | +45+8.2% | Added |
| Daiwa Securities Group Inc. | 169 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 200 | $664 | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 185 | $614 | 0.00% | +135+270.0% | Added |
| Royal Bank of Canada | 7 | $0 | 0.00% | +7 | New |
| Steward Financial Group LLC | 13 | $0 | 0.00% | +13 | New |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −848,412−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −577,250−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −25,333−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,600−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,836−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,542−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,530−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −312−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |